BioHarvest Sciences Inc.
BHST
$1.95
$0.042.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -40.67% | -19.83% | 12.30% | 38.41% | -74.51% |
| Total Depreciation and Amortization | 14.95% | -1.15% | 12.47% | -5.41% | 2.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 88.24% | -21.20% | 30.06% | -57.04% | 274.05% |
| Change in Net Operating Assets | -12,555.56% | 100.59% | -98.96% | -323.91% | 3,018.18% |
| Cash from Operations | -102.39% | 38.77% | -7.70% | -43.61% | -2.03% |
| Capital Expenditure | 4.22% | 9.33% | -53.88% | 28.21% | 13.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -7,042.86% | -- | -- | -100.00% |
| Cash from Investing | 64.34% | -138.47% | -57.18% | 28.21% | 12.94% |
| Total Debt Issued | -- | -- | -51.49% | 63.55% | -20.97% |
| Total Debt Repaid | 22.70% | 88.73% | -1,374.76% | -65.63% | -15.84% |
| Issuance of Common Stock | -- | -- | 229.83% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.70% | 15.09% | -- | -- | -- |
| Cash from Financing | 19.64% | -105.62% | 53.48% | 308.05% | -23.57% |
| Foreign Exchange rate Adjustments | 269.57% | -227.78% | 89.47% | 258.33% | -200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.54% | -131.99% | 66.58% | 2,120.55% | -67.75% |